Cargando…
Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson’s disease patients: A prospective cohort study (HP-PD trial)
BACKGROUND: Helicobacter pylori (HP) is a bacterium associated with many gastrointestinal (GI) diseases and has shown a high prevalence in Parkinson’s disease (PD). As HP-associated GI dysfunction could affect L-dopa (levodopa) absorption, HP eradication might improve the clinical response and decre...
Autores principales: | Lolekha, Praween, Sriphanom, Thanakarn, Vilaichone, Ratha-Korn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096108/ https://www.ncbi.nlm.nih.gov/pubmed/33945559 http://dx.doi.org/10.1371/journal.pone.0251042 |
Ejemplares similares
-
Low Re-infection Rate of Helicobacter pylori after Successful Eradication in Thailand: A 2 Years Study
por: Vilaichone, Ratha Korn, et al.
Publicado: (2017) -
Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)
por: Aumpan, Natsuda, et al.
Publicado: (2023) -
Management of Helicobacter pylori infection
por: Aumpan, Natsuda, et al.
Publicado: (2022) -
High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study
por: Poonyam, Piyakorn, et al.
Publicado: (2019) -
Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study
por: Chotivitayatarakorn, Peranart, et al.
Publicado: (2017)